Is Sodium Laureth Sulfate (SLES) Safer Than SLS or Still a Concern?

Sodium lauryl sulfate (CAS 151-21-3) and sodium laureth sulfate (CAS 9004-82-4) belong to the same anionic surfactant family, but the insertion of one to three ethylene oxide units in SLES changes the performance envelope, the impurity profile, and the toxicological endpoints that dominate safety assessment. SLS is produced by direct sulfation of narrow-cut C12 fatty alcohol using a falling-film SO3 reactor followed by immediate neutralization with aqueous sodium hydroxide; SLES is produced by first ethoxylating the C12 alcohol with gaseous ethylene oxide in a pressure reactor and then sulfating the alcohol ethoxylate. The safety comparison therefore does not reduce to a single irritancy ranking. SLS carries a higher intrinsic capacity for stratum corneum protein binding and lipid perturbation, while SLES carries a process-derived 1,4-dioxane risk that is absent from unethoxylated SLS. Regulatory evaluations under OECD 404 and OECD 439, human repeated insult patch testing, Proposition 65 dioxane thresholds, and production-scale purification variables all support the position that SLES exhibits lower acute dermal and ocular irritation than SLS at matched active concentrations, but SLES remains a concern when 1,4-dioxane stripping is incomplete or when acidic hydrolysis generates higher-penetration alcohol ethoxylate by-products.

Does the Irritation Differential Survive Standardized Patch Testing?

Under OECD 404 acute dermal irritation protocols, SLS at 1.0% w/w under occlusive patch conditions produces reproducible erythema and edema scores, while SLES at identical active concentration typically yields only slight or no visible erythema that resolves within 24 h. In human patch-test panels, 2.0% aqueous SLS is routinely used as an irritant positive control for sensitive skin validation because it induces barrier disruption, whereas 2.0% SLES with an average ethoxylation degree of 2 generally remains below the threshold for cumulative irritation. The OECD 439 reconstructed human epidermis assay codifies this difference by requiring 5.0% SLS as a positive control; a valid test must reduce relative MTT viability to below 50% after 15 min exposure and 42 h post-incubation. SLES tested under the same protocol often retains viability above 50%, yielding a non-irritant classification under UN GHS criteria. However, the standardized outcomes measure acute barrier damage, not repeated exposure on compromised skin or the influence of formulation pH and surfactant mixtures.

Mechanistically, the reduced irritation of SLES is linked to lower free monomer activity and a larger molecular headgroup. Surface tension data obtained under ASTM D1331-14 with a du Noüy ring tensiometer show that SLS reaches 35 mN/m near a critical micelle concentration of 8.2 mmol/L, whereas SLES with average 2 ethylene oxide units reaches equivalent surface pressure below 1.0 mmol/L. The lower CMC of SLES means that at equal formulated concentration, the equilibrium monomer population available to penetrate the stratum corneum is smaller. Closed-chamber transepidermal water loss measurements with an AquaFlux AF200 evaporimeter demonstrate that 1.0% SLS increases TEWL significantly after 4 h occlusion, while 1.0% SLES produces a smaller TEWL shift and faster recovery after removal. Protein denaturation assays involving zein solubilization under controlled pH 7.0 and 25°C show SLS binding more strongly than SLES at equivalent molar concentrations.

Ethylene Oxide Insertion Shifts the Toxicological Profile Toward a Different Risk Cluster

During SLES manufacture, lauryl alcohol is ethoxylated with gaseous ethylene oxide in a stirred pressure reactor using potassium hydroxide catalyst at temperatures of 140–160°C and pressures of 4–6 bar. The exothermic polyaddition generates a distribution of ethoxylate oligomers, but a competing reaction between two ethylene oxide molecules produces 1,4-dioxane, which is retained in the ethoxylate until purification. Residual dioxane is not an SLS issue because SLS manufacturing does not involve ethylene oxide. Industrial SLES paste is typically passed through a thin-film or wiped-film evaporator under vacuum at 80–120°C and 20–50 mbar to strip volatile dioxane and residual ethylene oxide; batches processed through short-path distillation with a residence time below 2 h and a condensate temperature below 10°C achieve lower residual dioxane than batches held in atmospheric neutralization kettles. Analytical verification by headspace GC-MS using selected ion monitoring and internal standard 1,4-dioxane-d8 follows EPA Method 8260D or validated in-house methods with detection limits near 0.1 mg/kg in paste. The California OEHHA Proposition 65 No Significant Risk Level for 1,4-dioxane is 30 µg/day, and this value is used in margin-of-safety calculations for leave-on and rinse-off products.

Formulation conditions modulate both the dioxane burden and the irritancy profile. In rinse-off compositions, the pH is typically maintained at 5.0–6.5 to minimize acid hydrolysis of the sulfate ester while remaining compatible with skin pH and preservative systems. Viscosity development in SLES-based systems relies on the salt curve; in a 10% active SLES base containing 2.0% sodium chloride at 25°C, a Brookfield LVDV-E viscometer with LV-4 spindle at 12 rpm commonly records viscosity between 3,000–8,000 mPa·s, whereas SLS under the same conditions shows phase separation or lower viscosity due to its greater sensitivity to electrolyte. Production-scale dosing of sodium chloride must be controlled with Coriolis mass flow meters to keep deviation within ±0.1% of target mass fraction; overshooting causes a gel phase that can cavitate lobe-type transfer pumps and create dead zones in the mixing vessel, increasing batch-to-batch variability.

When the Formulation pH Falls Below 4.0, SLES Hydrolysis Alters Both Irritation and Dioxane Release Kinetics

At pH values below 4.0, the acid-catalyzed hydrolysis of SLES at the sulfate ester linkage becomes relevant, especially during prolonged storage at 45°C or in acidic leave-on formulations. The hydrolysis liberates lauryl alcohol ethoxylates and sulfate species; lauryl alcohol ethoxylates have a higher octanol-water partition coefficient than the parent SLES and can penetrate the stratum corneum more efficiently, altering the irritation profile from the original surfactant. Simultaneously, acid-catalyzed hydrolysis of residual ethylene oxide may proceed to ethylene glycol, but 1,4-dioxane is comparatively stable under mild acidic conditions, so a low-pH formulation cannot be assumed to eliminate dioxane. Published kinetic data for cosmetic-grade SLES hydrolysis below pH 4.0 are limited and vary with ethoxylation distribution and counterion impurities; therefore, a universal half-life should not be applied without batch-specific accelerated stability testing at 45°C for 30 days. Analytics for such stability studies include reversed-phase HPLC with evaporative light scattering detection for lauryl alcohol ethoxylate distribution and headspace GC-MS for dioxane.

Ocular safety assessment of SLS and SLES employs OECD 437 bovine corneal opacity and permeability and OECD 492 reconstructed human corneal epithelium models. In BCOP testing, SLS at 10% aqueous produces corneal opacity scores and fluorescein permeability values that correlate with severe eye irritation, while SLES at 10% with average 2 ethoxylate units generally produces lower opacity and permeability, often below the threshold for classification. The BCOP model is not a complete replacement for the Draize rabbit eye test because it does not capture delayed vascular changes or pain responses. Manufacturers of baby shampoos and sensitive-skin cleansers therefore combine BCOP data with OECD 404 dermal irritation data, human repeat insult patch testing, and ophthalmologist-supervised in-use studies before making eye-compatibility claims. This evidence base explains why SLES is preferred over SLS in low-eye-irritation rinse-off products, but it does not eliminate the need for formulation-specific testing when SLES is blended with amphoteric surfactants or high-load fragrance systems.

Comparative characteristics of SLS and SLES under typical cosmetic-grade conditions

Parameter	SLS	SLES	Reference method or standard
CAS Registry Number	151-21-3	9004-82-4	CAS
Average ethylene oxide content	0	1–3 units	HPLC-ELSD
Critical micelle concentration in water	8.2 mmol/L	<1.0 mmol/L	ASTM D1331-14
Positive control status in skin irritation	5.0% positive control reduces viability below 50%	Generally retains viability above 50%	OECD 439
1,4-Dioxane formation potential	Absent	Present during ethoxylation; requires vacuum stripping	Headspace GC-MS EPA 8260D
Salt thickening response	Low electrolyte tolerance, phase separation	Viscosity 3,000–8,000 mPa·s at 2.0% NaCl in 10% active base	Brookfield LVDV-E at 12 rpm, 25°C

In high-volume sulfation plants, switchovers from SLS to SLES require different feed preheating because alcohol ethoxylates have higher viscosity than unethoxylated C12 alcohol at 40°C. Heat-traced lines and positive-displacement gear pumps are used to avoid flow interruptions that cause localized overheating and color formation in the falling-film reactor. Batch-to-batch variance in SLES paste is commonly assessed by measuring active matter content by hyamine titration per ISO 2271:1989. SLES paste is commonly supplied at 68–72% active matter; SLS is supplied as needles or powder at 90–96% active matter. Microbiological safety requires challenge testing of the finished formula per ISO 11930 because both SLS and SLES exhibit antimicrobial activity against Gram-positive organisms at high concentrations, but SLES is less potent at equivalent concentration and cannot replace a validated preservative system.

In continuous sulfation plants, the switch from SLS to SLES involves changing the fatty alcohol feed from exclusive C12 alcohol to an alcohol ethoxylate stream with a known molar ethylene oxide ratio determined by hydroxyl value titration. The falling-film sulfonation reactor must be tuned for higher viscosity of ethoxylated feed; line flushing with demineralized water between campaigns prevents cross-contamination of alkyl sulfate paste with ethoxylated sulfate paste in storage tanks. In-line pH measurement at the neutralization loop using high-temperature glass electrodes calibrated to pH 7.0 and 10.0 at 60°C ensures the SLES paste exits at pH 7.0–8.0, minimizing hydrolysis during storage. Residual 1,4-dioxane in the final paste is quantified by headspace GC-MS using 1,4-dioxane-d8 internal standard and a detection limit of 0.1 mg/kg; if the limit is exceeded, the batch is redirected to a wiped-film stripper operating at 90°C and 35 mbar for at least 2 h. This corrective loop is more robust for SLES than for SLS because SLS does not carry the dioxane risk but requires tighter control of pH and electrolyte to avoid stratification in post-sulfation neutralization.